80754-22-9

Basic information

• Product Name: Benzenepropanoic acid, 2-hydroxy-4-(methoxymethoxy)-, ethyl ester
• CAS NO: 80754-22-9
• Molecular Formula: C13H18O5
• Molecular Weight: 254.283
• Mol File: 80754-22-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzenepropanoic acid, 2-hydroxy-4-(methoxymethoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, 2-hydroxy-4-(methoxymethoxy)-, ethyl ester(80754-22-9)
• EPA Substance Registry System: Benzenepropanoic acid, 2-hydroxy-4-(methoxymethoxy)-, ethyl ester(80754-22-9)

Safety Data

• Hazardous Substances Data: 80754-22-9(Hazardous Substances Data)

Upstream product

• 441356-74-7 (E)-ethyl 3-[2-(benzyloxy)-4-(methoxymethoxy)phenyl]acrylate 
• 93-35-6 7-hydroxy-2H-chromen-2-one 
• 64-17-5 ethanol 
• 80754-21-8 7-(methoxymethoxy)-2H-chromen-2-one 

Downstream Products

• 80754-23-0 ethyl 3-<2-methoxy-4-(methoxymethoxy)phenyl>propanoate 
• 888740-08-7 ethyl 3-[2-([3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy)-4-(methoxymethoxy)phenyl]propanoate 
• 76907-79-4 xenognosin A 
• 80754-25-2 1-<4-(methoxymethoxy)phenyl>-3-<2-methoxy-4-(methoxymethoxy)phenyl>propan-1-ol 
• 80754-24-1 3-<2-methoxy-4-(methoxymethoxy)phenyl>propanal 
• 80754-26-3 ethyl 3-(4-hydroxy-2-methoxyphenyl)propanoate 
• 80754-27-4 3-(2-Methoxy-4-methoxymethoxy-phenyl)-propan-1-ol 

Relevant articles and documents

Synthesis and Carbon-13 Nuclear Magnetic Resonance Assignments of Xenognosin

Xenognosin (1) is a modified flavonoid isolated from gum tragacanth, and it stands as the first natural host recognition substance for parasitic angiosperms.Xenognosin (1) was synthesized by converting umbelliferone (2) to the key aldehyde 6 which was tre

THERAPEUTIC AGENT FOR DIABETES

The present invention provides an agent for the prophylaxis or treatment of diabetes, which is associated with a ferwer side effects such as body weight gain, adipocyte accumulation, cardiac hypertrophy and the like, and which contains a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.

ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF

An alkanoic acid derivative useful as a prophylactic or therapeutic agent of diabetes mellitus, hyperlipidemia, impaired glucose tolerance and the like can be provided by a compound represented by the formula wherein R1 is an optionally substituted 5-membered aromatic heterocyclic group; X is a bond and the like; Q is a divalent hydrocarbon group having 1 to 20 carbon atoms; Y is a bond and the like; ring A is an aromatic ring optionally further having 1 to 3 substituents; Z is -(CH2)n-Z1- (n is an integer of 1 to 8 and Z1 is an oxygen atom and the like) and the like; ring B is a pyridine ring optionally further having 1 to 3 substituents, and the like; U is a bond and the like; W is a divalent hydrocarbon group having 1 to 20 carbon atoms; and R3 is -OH and the like, provided that, when ring B is a benzene ring optionally further having 1 to 3 substituents, U should be a bond, or a salt thereof.